| |
2–3 HIV tests (n = 1384; 47 HIV+) median time first/last test 503 days (IQR, 317–845 days)
|
4–5 HIV tests (n = 565; 22 HIV+) median time first/last test 844 days (IQR, 567–1229 days)
|
6 or more tests (n = 508; 18 HIV+) median time first/last test 1333 days (IQR, 920–1705 days)
|
---|
Risk factor/risk behavior (within 12 months prior to test)
|
Prevalence of AEH per individuals that reported the risk a
|
First Test
|
Last Test
| |
First Test
|
Last Test
| |
First Test
|
Last Test
| |
---|
Individuals reporting risk (n,%)
|
Individuals reporting risk (n, %)
|
Difference in percentage, relative (absolute)
|
P value b
|
Individuals reporting risk (n, %)
|
Individuals reporting risk (n, %)
|
Difference in percentage, relative (absolute)
|
P value b
|
Individuals reporting risk (n, %)
|
Individuals reporting risk (n, %)
|
Difference in percentage, relative (absolute)
|
P value b
|
---|
10 or more male partners
|
3.8 %
|
456/1384 (32.95 %)
|
504/1384 (36.42 %)
|
+10.53 % (+3.47 %)
|
0.011
|
193/565 (34.16 %)
|
224/565 (39.65 %)
|
+16.07 % (+5.49 %)
|
0.012
|
198/508 (38.98 %)
|
223/508 (43.90 %)
|
+12.62 % (+4.92 %)
|
0.054
|
CRAI and 10 or more male partners
|
5.5 %
|
255/1384 (18.43 %)
|
301/1384 (21.75 %)
|
+18.01 % (+3.32 %)
|
0.006
|
101/565 (17.88 %)
|
132/565 (23.36 %)
|
+30.65 % (+5.48 %)
|
0.004
|
116/508 (22.83 %)
|
130/508 (25.59 %)
|
+12.09 % (+2.76 %)
|
n.s.
|
CRAI with HIV positive male
|
7.8 %
|
46/1277 (3.60 %)
|
72/1335 (5.39 %)
|
+49.72 % (+1.79 %)
|
n.s.
|
18/526 (3.42 %)
|
32/551 (5.81 %)
|
+69.88 % (+2.39 %)
|
n.s.
|
8/446 (1.79 %)
|
52/495 (10.51 %)
|
+487 % (+8.72 %)
|
<0.001
|
CRAI with sex worker
|
7.7 %
|
5/1350 (0.37 %)
|
6/1364 (0.44 %)
|
+10.45 % (+0.07 %)
|
n.s.
|
1/555 (0.18 %)
|
2/561 (0.36 %)
|
+100 % (+0.18 %)
|
n.s.
|
1/489 (0.20 %)
|
4/502 (0.80 %)
|
+300 % (+0.60 %)
|
n.s.
|
CRAI with PWID
|
10.3 %
|
9/1350 (0.67 %)
|
17/1365 (1.25 %)
|
+86.57 % (+0.58 %)
|
n.s.
|
5/555 (0.90 %)
|
13/559 (2.33 %)
|
+159 % (+1.43 %)
|
n.s.
|
0/491 (0 %)
|
9/498 (1.81 %)
|
+∞ (+1.81 %)
|
0.008
|
Any self-reported STI
|
4.6 %
|
155/1384 (11.20 %)
|
177/1384 (12.79 %)
|
+14.20 % (+1.59 %)
|
n.s.
|
64/565 (11.33 %)
|
87/565 (15.40 %)
|
+35.92 % (+4.07 %)
|
0.040
|
91/508 (17.91 %)
|
77/508 (15.16 %)
|
−15.35 % (−2.75 %)
|
n.s.
|
IDU with shared needles
|
7.8 %
|
4/1384 (0.29 %)
|
9/1384 (0.65 %)
|
+124 % (+0.36 %)
|
n.s.
|
2/565 (0.35 %)
|
5/555 (0.90 %)
|
+157 % (+0.55 %)
|
n.s.
|
0/508 (0 %)
|
3/508 (0.59 %)
|
+∞ (+0.59 %)
|
n.s.
|
Methamphetamine, not injected
|
6.2 %
|
77/1384 (5.56 %)
|
88/1384 (6.36 %)
|
+14.39 % (+0.80 %)
|
n.s.
|
28/565 (4.96 %)
|
35/565 (6.19 %)
|
+24.79 % (+1.23 %)
|
n.s.
|
26/508 (5.11 %)
|
38/508 (7.48 %)
|
+46.38 % (+2.37 %)
|
0.090
|
Non-injection stimulant drug use c
|
3.3 %
|
318/1384 (22.98 %)
|
411/1384 (29.70 %)
|
+29.24 % (+6.72 %)
|
<0.001
|
130/565 (23.01 %)
|
166/565 (29.38 %)
|
+27.58 % (+6.37 %)
|
0.002
|
96/508 (18.90 %)
|
163/508 (32.09 %)
|
+69.79 % (+13.19 %)
|
<0.001
|
- AEH, Acute and early HIV infection; CRAI, Condomless receptive anal intercourse; IQR, Interquartile range; IDU, Injection drug use; n.s., Not significant; PWID, Person who injects drugs; STI, Sexually transmitted infection; a Among whole MSM study population after exclusion of those with newly diagnosed chronic HIV infection
- b Calculated using McNemara test; P value displayed when below 0.1
- c i.e. Methamphetamine, cocaine, poppers, Gamma hydroxybutyrate, ketamine, ecstasy